Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.68 |
| ▸ | TOP1 | P11387 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | ARG2 | P78540 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2353514 | 1.00 | MAOB (0.68) | MAOBTOP1KCNH2CA1CA2 | |
| SCHEMBL28347614 | 0.88 | MAOB (0.52) | MAOBTOP1KCNH2CA1CA2 | |
| SCHEMBL19031833 | 0.87 | MAOB (0.62) | MAOBTOP1KCNH2CA1CA2 | |
| SCHEMBL19031834 | 0.87 | MAOB (0.62) | MAOBTOP1KCNH2CA1CA2 | |
| SCHEMBL19031836 | 0.85 | MAOB (0.60) | MAOBTOP1KCNH2EPHX2FAAH | |
| SCHEMBL19031835 | 0.85 | MAOB (0.60) | MAOBTOP1KCNH2EPHX2FAAH | |
| SCHEMBL19031851 | 0.84 | KCNH2 (0.59) | MAOBTOP1KCNH2EPHX2FAAH | |
| SCHEMBL20421295 | 0.84 | TOP1 (0.59) | MAOBTOP1KCNH2EPHX2FAAH | |
| SCHEMBL17027721 | 0.84 | KCNH2 (0.59) | MAOBTOP1KCNH2EPHX2FAAH | |
| SCHEMBL17027720 | 0.84 | KCNH2 (0.59) | MAOBTOP1KCNH2EPHX2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110207637-A1 | Vicinally Disubstituted Internal Olefins as Constituents of Olefin Copolymers for Lubricating Oil Rheology Modifiers | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-08-25 | — | — | US | claimed |
| US-7037989-B2 | Copolymers of ethylene and/or α-olefins and vicinally disubstituted olefins | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-05-02 | — | — | US | claimed |
| WO-2004106394-A1 | COPOLYMERS OF ETHYLENE AND/OR α-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-12-09 | — | — | WO | claimed |
| US-20040242814-A1 | COPOLYMERS OF ETHYLENE AND/OR ALPHA-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-02 | — | — | US | claimed |
| EP-1047654-A1 | METHOD FOR PRODUCING 2,6-DMN FROM MIXED DIMETHYLNAPHTHALENES BY CRYSTALLIZATION, ADSORPTION AND ISOMERIZATION | Chevron Chemical Company LLC (US) | 2000-11-02 | — | — | EP | claimed |
| US-6057487-A | PRECIPITATION AND SEPARATION SUPERNATANT WITH 2,6-DIMETHYLNAPHTHALENE | CHEVRON CHEMICAL COMPANY (US) | 2000-05-02 | — | — | US | claimed |
| WO-1999033770-A1 | METHOD FOR PRODUCING 2,6-DMN FROM MIXED DIMETHYLNAPHTHALENES BY CRYSTALLIZATION, ADSORPTION AND ISOMERIZATION | CHEVRON CHEMICAL COMPANY LLC (US) | 1999-07-08 | — | — | WO | claimed |
| EP-4431180-A2 | OLEFIN METATHESIS CATALYSTS | Umicore AG & Co. KG (DE) | 2024-09-18 | — | — | EP | disclosed |
| EP-3386936-B1 | OLEFIN METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024099911-A1 | IRON CARBONYL COMPLEXES WITH CHIRAL, BIDENTATE BIPHOSPHINE LIGANDS | BASF SE (DE) | 2024-05-16 | — | — | WO | disclosed |
| US-11306041-B2 | Catalytic synthesis of super linear alkenyl arenes using rhodium catalysts | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-04-19 | — | — | US | disclosed |
| US-RE49036-E1 | Method for synthesizing optically active carbonyl compounds | BASF SE (DE) | 2022-04-19 | — | — | US | disclosed |
| CN-108368001-B | Olefin metathesis catalysts | 优美科股份公司及两合公司 | 2021-07-23 | — | — | CN | disclosed |
| US-5637644-A | Process for producing copolymer latex and paper coating composition, carpet backing composition or adhesive composition comprising said latex | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1997-06-10 | — | — | US | disclosed |
| US-5444118-A | Emulsion polymerizing in two stages conjugated diene, unsaturated acid, other unsaturated compound in presence of alpha-methylstyrene dimer | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1995-08-22 | — | — | US | disclosed |
| EP-0407059-B1 | Process for producing copolymer latex and paper coating composition, carpet backing composition or adhesive composition comprising said latex | JAPAN SYNTHETIC RUBBER CO LTD (JP) | 1994-11-09 | — | — | EP | disclosed |
| US-5017724-A | Antihypoxic, CNS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| EP-0267024-B1 | HYDROFLUORENE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | EP | disclosed |
| EP-0407059-A2 | Process for producing copolymer latex and paper coating composition, carpet backing composition or adhesive composition comprising said latex | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-01-09 | — | — | EP | disclosed |
| EP-0267024-A2 | Hydrofluorene derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306041-B2 | Catalytic synthesis of super linear alkenyl arenes using rhodium catalysts | MSMO1, CYP2E1, PNMT | MAOB 241/4885TOP1 613/4885KCNH2 2920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.